FDA declines to issue specific guidance on health programs' foreign drug imports
A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S. regulators say is a violation of import laws.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief